Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06570850
PHASE4

Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection

Sponsor: Chiang Mai University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand. The main questions it aims to answer the following main questions: 1. Which group has better clinical response at end of treatment 2. Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment

Official title: Efficacy of Colistin Monotherapy Versus Colistin Combined With Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii Infections

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

188

Start Date

2023-04-01

Completion Date

2025-07

Last Updated

2024-08-26

Healthy Volunteers

No

Interventions

DRUG

Colistin Sodium Methanesulfonate

Intravenous colistin (colistinmethate soidum) 5 mg/kg/day intravenous (dosage will be adjusted according to creatinine clearance). The duration of treatment ranges from 10 to 14 days, depending on the site of infection and clinical responsiveness.

DRUG

Colistin Sodium Methanesulfonate plus Fosfomycin

Intravenous colistin(dosage is same as colistin group) plus intravenous fosfomycin(dosage will be adjusted according to MIC and creatinine clearance). The duration of treatment ranges from 10 to 14 days, depending on the site of infection and clinical responsiveness.

Locations (1)

Faculty of medicine, Chiang Mai university

Chiang Mai, Thailand